Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative
2022
3 görüntülenme
0 i̇ndirme
Danışman: Prof. Dr. Catherıne Macmıllan
Özet (EN)
This thesis aims to study feminist revisionist rewritings of selected ancient Greek and Roman myths to show the violation of women in myth, its links to today's society and how feminist rewritings change the narration and empower mythological and real women by giving these mythical women voices to tell their own versions of the stories. The mythical women in question are; Daphne, Pygmalion's Statue, Circe and Medusa. They are all studied firstly through Ovid's Metamorphoses, then secondly the other ancient texts (Virgil's Aeneid, Homer's Odyssey, Parthenius's Erotika Pathemata etc.) that have originated or added to their myths and lastly some feminist rewritings of these myths by contemporary writers in different genres such as; Carol Ann Duffy, Ann Stanford, Nina MacLaughlin, Alicia Stallings, Madeline Miller and Micheal Kasenow with the use of feminist theories and theories about the psychology of violation of women. Keywords: rewritings, mythology, feminism, violation.
Yazar
Sena Tuğçe Gürkan
Bu Yayına Nasıl Atıf Yapılır
Sena Tuğçe Gürkan (Master Thesis). Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative, 2022, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)
- Declaration obligation of the insurant during the conclusion of the contract(2021)